MedPath

Novlead, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Inhaled Nitric Oxide for High Amplitude Pulmonary Edema (HAPE)

Not Applicable
Recruiting
Conditions
High Altitude Pulmonary Hypertension
First Posted Date
2025-02-28
Last Posted Date
2025-02-28
Lead Sponsor
Novlead Inc.
Target Recruit Count
100
Registration Number
NCT06852924
Locations
🇨🇳

Tibet Fokang Hospital, Lasa, Tibet, China

FeNO Detection in Asthma Diagnosis: A New Technology Approach

Not Applicable
Recruiting
Conditions
Bronchial Asthma
Airway Disease
First Posted Date
2025-02-28
Last Posted Date
2025-02-28
Lead Sponsor
Novlead Inc.
Target Recruit Count
170
Registration Number
NCT06852911
Locations
🇨🇳

Ruijin Hospital, Shanghai, Shanghai, China

🇨🇳

Wuxi Xinwu District Xinrui Hospital, Wuxi, China

A Real-world Study of Nitric Oxide Generator and Delivery System

Recruiting
Conditions
Pulmonary Hypertension of Newborn
First Posted Date
2023-01-27
Last Posted Date
2025-02-19
Lead Sponsor
Novlead Inc.
Target Recruit Count
10
Registration Number
NCT05703191
Locations
🇨🇳

ZhuJiang Hospital of Southern Medical University, Guangzhou, Guangzhou, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.